Label Comprehension Studies Must Account For Drugs’ Complexity – Bull
This article was originally published in The Tan Sheet
Executive Summary
The science behind creating OTC labeling and label comprehension studies needs to be improved to account for the increasing complexity of nonprescription drugs and their indications, stated Center for Drug Evaluation & Research Office of Drug Evaluation V Director Jonca Bull, MD
You may also be interested in...
Labels May Need Explicit References To Consequences Of Misuse – Ganley
Frequent occasions of drug-label comprehension not predicting appropriate use suggest that OTC drug labels need more explicit language, FDA's Office of Nonprescription Products director says
Labels May Need Explicit References To Consequences Of Misuse – Ganley
Frequent occasions of drug-label comprehension not predicting appropriate use suggest that OTC drug labels need more explicit language, FDA's Office of Nonprescription Products director says
Labels May Need Explicit References To Consequences Of Misuse – Ganley
Frequent occasions of drug-label comprehension not predicting appropriate use suggest that OTC drug labels need more explicit language, FDA's Office of Nonprescription Products director says